Enteric coating of mycophenolate sodium: a rational approach to limit topical gastrointestinal lesions and extend the therapeutic index of mycophenolate
- 1 November 2001
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 33 (7-8) , 3238-3240
- https://doi.org/10.1016/s0041-1345(01)02377-6
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Cytomegalovirus Infection and Abdominal Pain with Mycophenolate MofetilDrug Safety, 2001
- The use of mycophenolate mofetil in transplant recipientsImmunopharmacology, 2000
- Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patientsClinical Transplantation, 2000
- FOUR-YEAR FOLLOW-UP OF MYCOPHENOLATE MOFETIL FOR GRAFT RESCUE IN LIVER ALLOGRAFT RECIPIENTS1Transplantation, 1999
- Intestinal permeability and inflammation in patients on NSAIDsGut, 1998
- Mitochondrial damage: a possible mechanism of the “topical” phase of NSAID induced injury to the rat intestineGut, 1997
- Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejectionThe Lancet, 1995
- Pathophysiology of nonsteroidal anti-inflammatory drug-induced intestinal stricturesGastroenterology, 1993
- Mycophenolic Acid in the Treatment of PsoriasisArchives of Dermatology, 1977
- Treatment Of Psoriasis With Oral Mycophenolic AcidJournal of Investigative Dermatology, 1975